RT @ThomasCiullaMD: Looking forward to presenting on #suprachoroidal delivery at the Ophthalmology Innovation Source Drug Delivery Innovati… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @BauschSurgical: B+L and Clearside Biomedical announce the FDA approval of XIPERE™ which utilizes the suprachoroidal space to treat pati… Source by Thomas Ciulla, MD, MBA Return to main website.
Looking forward to presenting on #suprachoroidal delivery at the Ophthalmology Innovation Source Drug Delivery Innovation Showcase!
#eye #retina #drugdelivery #genetherapy #biotech https://t.co/QC85uDRp2f
Source by Thomas Ciulla, MD, MBA
Just published, “RPE65 Mutation-associated Inherited Retinal Disease and Gene Therapies”. #eye #ophthalmology #retina #gene #IRD #genetherapy #clinicalresearch #clinicaltrials #drugdevelopment #biotech https://t.co/4zpccyQV2P Source by Thomas Ciulla, MD, MBA Return to main website.
RT @OTEurope: XIPERE, the first therapy utilising the suprachoroidal space, demonstrates rapid efficacy, durable benefit and favourable saf… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Honored to have been interviewed by @retinapodcast on research, roles in industry, and innovations in retinal therapeut…
Source by Thomas Ciulla, MD, MBA
Suprachoroidal RGX-314 well tolerated, improves visual acuity in initial results https://t.co/HZmaJEVIAc Source by Thomas Ciulla, MD, MBA Return to main website.
RT @AuraBiosciences: Aura is proud to share that Dr. Hakan Demirci’s scientific poster updating the safety data of the Phase 2 AU-011 trial… Source by Thomas Ciulla, MD, MBA Return to main website.
Congrats to colleagues, partners & team, with numerous #aao2021 & AUS presentations on #suprachoroidal delivery, utilizing the SCS Microinjector. Beyond recently FDA-approved #Xipere, 4 clinical trials are now assessing 3 suprachoroidal therapies.
#eye #retina #genetherapy https://t.co/25TR3ccT06
Source by Thomas Ciulla, MD, MBA
RT @RetinalPhys: Data Presented From 2 Regenxbio Trials: ALTITUDE and AAVIATE trials promising for subretinal and suprachoroidal delivery o… Source by Thomas Ciulla, MD, MBA Return to main website.